Clik here to view.
GVK BIOが新しい適応症発見のための医薬品再開発事業を成功裏に完了と発表
印ハイデラバード （ビジネスワイヤ） — アジア一流の総合創薬・研究開発組織であるGVKバイオサイエンシズ（GVK BIO）は本日、武田薬品工業株式会社向けに、GVK BIO専有の医薬品再開発プラットフォームを活用して、棚上げされた化合物の代替適応症をコンピューター上で確認することに成功したと発表しました。GVK...
View ArticleClik here to view.
GVK BIO Announces Successful Completion of Drug Repurposing Efforts to...
HYDERABAD, India GVK Biosciences (GVK BIO), Asia’s leading integrated Discovery Research and Development organization, today announced the successful completion of in-silico based alternative...
View ArticleClik here to view.
エリテック、米国で新たな特許が付与されたと発表
仏リヨン （ビジネスワイヤ） — 急性白血病および医療ニーズが満たされていないその他の腫瘍適応症を対象に革新的な「腫瘍飢餓化」治療薬の開発に当たっているフランスのバイオ製薬企業エリテック（Paris:ERYP）（Euronext Paris: FR0011471135 – ERYP）は、アスパラギナーゼの分野で新たな特許が米国で付与されたことを発表します。 特許（WO 2010/052315...
View ArticleClik here to view.
Aortic Valve Stenosis Treatment in Thailand by Phyathai 2 International Hospital
BANGKOK Phyathai 2 International Hospital’s Heart Center uses the latest techniques and technology available to investigate any heart conditions and provide the best treatment for patients of all...
View ArticleClik here to view.
The Region Zealand Gives Top Priority to Staff Safety in New Hospital
GOTHENBURG, Sweden With an investment of more than DKK 4 million, Zealand has opted for a thoroughly tested alarm solution from the leading supplier in this field, Ascom, which also stands behind...
View ArticleClik here to view.
Gynesonics Receives FDA Approval to Commence a Pivotal IDE Clinical Trial for...
REDWOOD CITY, Calif. Gynesonics, Inc., a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, today announced it has received...
View ArticleClik here to view.
Foundation Medicine and WuXi PharmaTech Announce Strategic Collaboration to...
CAMBRIDGE, Mass. & SHANGHAI Foundation Medicine, Inc. (NASDAQ:FMI) and WuXi PharmaTech (Cayman) Inc. (NYSE:WX) today announced a collaboration to offer Foundation Medicine’s comprehensive...
View ArticleClik here to view.
Enigma Diagnostics Signs Joint Venture Agreement with Beijing Leadman...
SALISBURY, England & BEIJING Enigma Diagnostics Ltd (Enigma), a global leader in molecular diagnostic point-of-care (PoC) infectious disease testing, and Beijing Leadman Biochemistry Co., Ltd....
View ArticleClik here to view.
Leading Pharmaceutical Company in Indonesia, PT. Combiphar, Partners With...
JAKARTA, Indonesia Korn Ferry (NYSE:KFY), a single source of leadership and talent consulting services, announced today that it has entered into a new partnership with PT. Combiphar to manage the...
View ArticleClik here to view.
R-Tech Ueno: Sucampo and Takeda Enter into Global Licensing Agreement for...
TOKYO R-Tech Ueno (JASDAQ:4573): Sucampo Pharmaceuticals, Inc. (“Sucampo”) and Takeda Pharmaceutical Company Limited (Takeda) announced that on October 17, 2014, they have entered into a global...
View ArticleClik here to view.
Enigma Diagnostics与北京利德曼生化股份有限公司签署合资协议，并宣布一项5000万美元的投资
英格兰索尔兹伯里和北京 (美国商业资讯) — 分子诊断床边(point-of-care)感染性疾病检测的全球领先者Enigma Diagnostics Ltd (Enigma)与北京利德曼生化股份有限公司（Beijing Leadman Biochemistry Co.,...
View ArticleClik here to view.
CardioKinetix Initiates Study in China of First-of-Its-Kind Parachute Device...
MENLO PARK, Calif. CardioKinetix Inc., a medical device company pioneering a catheter-based treatment for heart failure, today announced the enrollment of the first patients in PARACHUTE China, a...
View ArticleClik here to view.
CardioKinetix在中国启动治疗心力衰竭的同类器械中首款Parachute器械的研究
加州门洛帕克 (美国商业资讯) — CardioKinetix Inc.是一家心力衰竭导管治疗领域的先驱性医疗器械公司。该公司今天宣布，Parachute研究在中国入组首例患者，该研究为多中心试验，旨在评估微创Parachute®心室隔离器械用于治疗心力衰竭。 最初10例患者在北京大学和阜外医院，以及上海第十人民医院经Parachute器械进行了治疗。...
View ArticleClik here to view.
Europe Approves Novel Australian Drug Developed for Rare Sun Disease
ZUG, Switzerland & MELBOURNE, Australia The first new pharmaceutical drug invented and developed for an untreated disorder by any Australian company has received regulatory approval from the...
View ArticleClik here to view.
A Novel Lectin Was Isolated by the Research Team of Jinchi Biotech Ltd. (JBL)
ZHANGJIAJIE, China Lately, Andrias Davidianus Lectin (ADL) was isolated successfully from the body-surface mucus of Andrias Davidianus (Giant Salamander) by JBL Research Team who had done 3 years of...
View ArticleClik here to view.
ChinaBio® Partnering Forum 2015 to be held in Shanghai, China April 22–23, 2015
CARLSBAD, Calif. & SHANGHAI The 2015 edition of ChinaBio® Partnering Forum, China’s premier life science partnering event, will be held April 22–23 in Shanghai. Shanghai is the largest city...
View ArticleClik here to view.
Akebia Announces Positive Top-Line Results from its Phase 2b Study of...
CAMBRIDGE, Mass. Akebia Therapeutics, Inc. (NASDAQ:AKBA), a biopharmaceutical company focused on delivering innovative therapies to patients with kidney disease through the biology of hypoxia...
View ArticleClik here to view.
NovaBay Pharmaceuticals Receives 2nd Major NeutroPhase Order for 150,000...
EMERYVILLE, Calif. NovaBay® Pharmaceuticals, Inc. (NYSE MKT:NBY), a biopharmaceutical company focusing on the development and commercialization of its non-antibiotic anti-infective products, today...
View ArticleClik here to view.
ZRG Partners Life Sciences Hiring Index Shows Double Digit Increases Over 2013
WEST ORANGE, N.J. ZRG Partners, Inc. announces the results of its third quarter Global Life Sciences Hiring Index. The Index posts its highest score in nearly five years, even with the European...
View ArticleClik here to view.
Cardiovascular Systems Enrolls First Seven Patients in Japan for Coast Study
ST. PAUL, Minn. Cardiovascular Systems, Inc. (CSI) (NASDAQ: CSII), announced that the first seven patients in Japan have been enrolled in its Coronary Orbital Atherectomy System Trial (COAST) study....
View Article